Evidence map›Paper›PMID 40208590›Full record

ArticleJAMA network open2025

Survival Outcomes After Multiple vs Single Arterial Grafting Among Patients With Reduced Ejection Fraction.

Justin Ren, Jason E Bloom, William Chan, Christopher M Reid, Julian A Smith, Andrew Taylor, David Kaye, Colin Royse, David H Tian, Andrea Bowyer and 2 more

Abstract readMulticenter StudyComparative Study
In one paragraph

Article in JAMA network open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Justin RenDepartment of Surgery, The University of Melbourne, Melbourne, Australia.
Jason E BloomBaker Heart and Diabetes Institute, Melbourne, Australia.
William ChanBaker Heart and Diabetes Institute, Melbourne, Australia.
Christopher M ReidPopulation Health, Curtin University, Perth, Australia.
Julian A SmithDepartment of Surgery, Monash University, Melbourne, Australia.
Andrew TaylorDepartment of Cardiology, Royal Melbourne Hospital, Melbourne, Australia.
David KayeBaker Heart and Diabetes Institute, Melbourne, Australia.
Colin RoyseDepartment of Surgery, The University of Melbourne, Melbourne, Australia.
David H TianDepartment of Surgery, The University of Melbourne, Melbourne, Australia.
Andrea BowyerDepartment of Surgery, The University of Melbourne, Melbourne, Australia.
Doa El-AnsaryDepartment of Surgery, The University of Melbourne, Melbourne, Australia.
Alistair RoyseDepartment of Surgery, The University of Melbourne, Melbourne, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Importance: Multiarterial coronary bypass procedures offer improved clinical outcomes compared with single arterial grafting with supplementary saphenous vein grafts. However, the survival advantage of multiarterial grafting across varying levels of left ventricular impairment remains uncertain. Objective: To compare long-term survival outcomes of patients undergoing multiple vs single arterial grafting, stratified by preoperative ejection fraction. Design, Setting, and Participants: A complete-case retrospective cohort study was conducted using data from a multicenter population-based cardiac registry established by the Australian & New Zealand Society of Cardiac & Thoracic Surgeons with linkage to the National Death Index. Participants were individuals who underwent primary isolated coronary bypass surgery between June 1, 2001, and January 31, 2020. Exclusion criteria were nonadults, reoperations, concomitant or previous cardiac surgical procedures, single-graft procedure, and cases without any arterial grafts. Statistical analyses were conducted in September 2024. Exposures: Patients underwent either multiple or single arterial grafting, stratified by their preoperative left ventricular ejection fraction. Main Outcomes and Measures: Long-term all-cause mortality. Results: The study included 59 641 patients (mean [SD] age at the time of surgery, 65.8 [10.2] years; 48 321 men [81.0%]). The median follow-up duration was 5.0 years (IQR, 2.3-8.6 years). Multiarterial grafting was associated with a 19.0% relative reduction in all-cause mortality compared with single arterial grafting among patients with a normal left ventricular ejection fraction (hazard ratio [HR], 0.81; 95% CI, 0.75-0.87; P < .001). Similar survival benefits were observed among patients with mild (HR, 0.83; 95% CI, 0.77-0.90; P < .001), moderate (HR, 0.82; 95% CI, 0.74-0.90; P < .001), and severe left ventricular impairment (HR, 0.82; 95% CI, 0.71-0.96; P = .01). A multivariable Cox proportional hazards regression interaction-term analysis indicated no significant differences in the multiarterial survival benefit by ejection fraction stratification (P = .75). Multiarterial grafting with exclusively arterial conduits was associated with enhanced survival benefits compared with other multiarterial procedures with saphenous vein grafts, except when the left ventricular ejection fraction was below 30% (HR, 0.87; 95% CI, 0.67-1.13; P = .30). Conclusions and Relevance: In this retrospective cohort study using data from a binational database, multiarterial procedures were associated with reduced long-term mortality risk compared with single arterial grafting across the spectrum of preoperative left ventricular ejection fractions. Total arterial revascularization was associated with incrementally improved survival, particularly among patients with preserved ejection fraction. Because most coronary surgery practice continues to use single arterial grafting, consideration to alter grafting strategy to multiarterial procedures may be indicated.

Indexed as

Coronary Artery BypassCoronary Artery DiseaseStroke VolumeVentricular Dysfunction, LeftAgedAustraliaFemaleHumansMaleMiddle AgedNew ZealandRegistriesRetrospective StudiesTreatment Outcome

Identifiers

PMID40208590
PMCPMC11986767

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.